Patents by Inventor Maria Carmen Pardina Palleja

Maria Carmen Pardina Palleja has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transvaginal phosphodiesterase inhibitors for infertility treatment
    Patent number: 9801885
    Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
    Type: Grant
    Filed: June 16, 2016
    Date of Patent: October 31, 2017
    Assignee: PROKREA BCN, S.L.
    Inventors: Maria Carmen Pardina Palleja, Miguel Angel Vaz-Romero Uña, Jose Maria Palacios Santibañez, Jose Luis Fabregas Vidal
  • TRANSVAGINAL PHOSPHODIESTERASE INHIBITORS FOR INFERTILITY TREATMENT
    Publication number: 20160287598
    Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
    Type: Application
    Filed: June 16, 2016
    Publication date: October 6, 2016
    Applicant: PROKREA BCN, S.L.
    Inventors: Maria Carmen PARDINA PALLEJA, Miguel Angel VAZ-ROMERO UÑA, Jose Maria PALACIOS SANTIBAÑEZ, Jose Luis FABREGAS VIDAL
  • TRANSVAGINAL PHOSPHODIESTERASE INHIBITORS FOR INFERTILITY TREATMENT
    Publication number: 20160074407
    Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
    Type: Application
    Filed: November 24, 2015
    Publication date: March 17, 2016
    Applicant: PROKREA BCN, S.L.
    Inventors: Maria Carmen PARDINA PALLEJA, Miguel Angel VAZ-ROMERO UÑA
  • Transvaginal phosphodiesterase inhibitors for infertility treatment
    Patent number: 9220679
    Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
    Type: Grant
    Filed: June 20, 2012
    Date of Patent: December 29, 2015
    Assignee: PROKREA BCN, S.L.
    Inventors: Maria Carmen Pardina Palleja, Miguel Angel Vaz-Romero Uña
  • TRANSVAGINAL PHOSPHODIESTERASE INHIBITORS FOR INFERTILITY TREATMENT
    Publication number: 20140194448
    Abstract: The present invention relates to a new application of phosphodiesterase inhibitors for couple infertility treatment which forms an effective alternative to the invasive assisted reproductive techniques such as conjugal artificial insemination and which consists of the transvaginal administration of a phosphodiesterase inhibitor immediately before and/or after coitus. It also relates to dosage forms suitable for the intravaginal administration of phosphodiesterase inhibitors.
    Type: Application
    Filed: June 20, 2012
    Publication date: July 10, 2014
    Inventors: Maria Carmen Pardina Palleja, Miguel Angel Vaz-Romero Uña